Claude Nicaise, M.D.

Claude Nicaise, M.D.

DirectoratSarepta Therapeutics· In proxies 2023–2025

Claude Nicaise, M.D. sits on 12 public boards.

Boards3

  • Filana TherapeuticsChair · 2 yr on the boardIndependentNominating and Governance—Paid as an executive
  • Sarepta TherapeuticsDirector · 10 yr on the boardIndependentCompensation, Research and Development—Paid as an executive
  • Gain TherapeuticsDirector · 4 yr on the boardIndependentCompensation, Nominating and Corporate Governance—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Sarepta TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -85%
  2. Filana TherapeuticsPublic company · 3 yr
    • Chair of the Board2023 – Present · 3 yrNo stock prices for these years
  3. Gain TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  4. Cassava Sciences, Inc.Public company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  5. Chemomab Therapeutics LtdPublic company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  6. Gain TherapeuticsPublic company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  7. ResearchPublic company · 11 yr
    • Director2015 – Present · 11 yrNo stock prices for these years
  8. Filana Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  9. RaySearch Laboratories ABPublic company
    • Director? – PresentNo stock prices for these years
  10. Rhenman & Partners Asset Management ABPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?